Financials
- Market Capitalization 3.5 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
51.34
Relación precio/flujo de caja
6.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1513 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.06 USD | -8.73% | +3.13% | -8.01% | +163.56% | 3.72 B USD | ||
| 1517 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.87 USD | -3.72% | +0.65% | -11.12% | +72.27% | 3.68 B USD | ||
| 1578 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 34.64 USD | -3.27% | -3.86% | -41.64% | -15.08% | 3.35 B USD | ||
| 1582 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 34.55 USD | -4.19% | -5.68% | -10.26% | +6.05% | 3.33 B USD |